This week's episode discusses the EU's research and innovation budget; Italy's AIFA responding to physician criticism of new guidelines and Oxford Biomedica's $842 million deal with Axovan Sciences.
Presenter: Max Rex
Contributors:
Aparna Krishnan, Corporate Affairs Lead
Joanna Fernandes, Consultant
view more